184 related articles for article (PubMed ID: 23025365)
1. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
2. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
3. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
5. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
6. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
7. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
8. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
Boniol M; Armstrong BK; Doré JF
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
10. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
[TBL] [Abstract][Full Text] [Related]
11. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
12. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
14. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
Giles G; Staples M; McCredie M; Coates M
Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
[TBL] [Abstract][Full Text] [Related]
16. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
17. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
18. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
19. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
20. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]